Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel.

Lorrain J, Lechaire I, Gauffeny C, Masson R, Roome N, Herault JP, O'Connor SE, Schaeffer P, Herbert JM.

J Pharmacol Exp Ther. 2004 Apr;309(1):235-40. Epub 2004 Jan 12.

PMID:
14718579
2.

Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.

Lorrain J, Millet L, Lechaire I, Lochot S, Ferrari P, Visconte C, Sainte-Marie M, Lunven C, Berry CN, Schaeffer P, Herbert JM, O'Connor SE.

J Pharmacol Exp Ther. 2003 Feb;304(2):567-74.

PMID:
12538808
3.

Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.

Berry CN, Lorrain J, Lochot S, Delahaye M, Lalé A, Savi P, Lechaire I, Ferrari P, Bernat A, Schaeffer P, Janiak P, Duval N, Grosset A, Herbert JM, O'Connor SE.

Thromb Haemost. 2001 Mar;85(3):521-8.

PMID:
11307825
5.

Ecarin Clotting Time: a predictive coagulation assay for the antithrombotic activity of argatroban in the rat.

Berry CN, Lunven C, Girardot C, Lechaire I, Girard D, Charles MC, Ferrari P, O'Brien DP.

Thromb Haemost. 1998 Jan;79(1):228-33.

PMID:
9459352

Supplemental Content

Loading ...
Support Center